Japan PHarmacological Audit study of Safety and Efficacy in Real world (Phase-R) ESAS Study
Not Applicable
- Conditions
- Malignancy
- Registration Number
- JPRN-UMIN000025269
- Lead Sponsor
- The University of Tokyo, The Institute of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who cannot answer ESAS scoring due to consciousness disturbance or severe deterioration.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method